Study to Assess the Incidence of Local Oropharyngeal and Laryngeal Adverse Effects of Advair DISKUS 250/50 mcg BID

NCT00235053 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

13

Enrollment

OTHER

Sponsor class

Conditions

Asthma
Candidiasis, Oral
Voice Disorders

Interventions

DRUG: fluticasone/salmeterol DISKUS 250/50

Sponsor

Allergy & Asthma Medical Group & Research Center